IL1B and pancreatic ductal adenocarcinoma: In Pancreatic ductal adenocarcinoma (PDAC) mouse models, adipocyte-secreted IL-1β could promote obesity-induced pancreatic carcinogenesis and drug resistance through recruitment of tumor-associated neutrophils [24].